NEW YORK (GenomeWeb) – Researchers at Sandia National Laboratories have been awarded a grant to develop a field-deployable assay for differential diagnosis of malaria and viral febrile illness.

The two-year grant from the National Institute of Allergy and Infectious Disease totals $188,759 and is expected to fund the proof-of-concept phase of the project. The Sandia research team will also be collaborating with researchers at the Institute for Human Health and Immunity at the University of Texas Medical Branch in Galveston.